Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

This study tests a new medication called efsubaglutide alfa to help people with overweight or obesity lose weight. About 200 adults will receive either the drug or a placebo for 22 weeks. The main goal is to see how much weight they lose and if the treatment is safe.